Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.
2don MSN
Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...
"On February 26, 2025, the US FDA issued a Warning Letter to Granules' Gagillapur facility based on its inspection conducted ...
The Warning Letter is dated February 26, 2025 and the facility continues to hold an "Official Action Indicated" (OAI) status.
USFDA issues warning letter for Granules India Gagillapur plant, new product approvals to take a hit
The USFDA issued a warning letter to Granules India Ltd's Gagillapur facility after an August 2024 inspection highlighted ...
Granules India's Gagillapur facility receives FDA warning letter, impacting product submissions review until resolved, company remains confident in resolution.
The development may temporarily delay the approval of pending product submissions from the site, but existing manufacturing ...
Drug firm Granules India Ltd on Thursday (February 27) announced that the US FDA has issued a Warning Letter for its ...
The combined organization represents operators across 38 states and a substantial amount of the 13,000 retail locations and ...
5d
Hosted on MSNNext Science sinks after FDA warning letter implies product could have caused injuryNext Science (ASX:NXS) shares fell -13% on Tuesday morning trades, to 10cps, after the company revealed it’s received a ...
Seeing the words "Class I food recall" might make you think of contaminated products sitting on grocery store shelves, but ...
USFDA issues warning letter to Jagsonpal Pharmaceuticals for manufacturing lapses at Rajasthan plant, demands corrective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results